drugset
drugset / Trial / NCT02929719

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

NCT02929719 ↗

Phase 1 Completed 1134 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Therapeutic equivalence and safety study

Timeline

Start
2014-04
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapsone Small molecule 5 % Topical

Indications

acne